A Phase II Study of Taxotere and Gemcitabine for Stages III-B and IV Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2017
At a glance
- Drugs Docetaxel (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2012 Actual end date (1 Sep 2007) added as reported by ClinicalTrials.gov.
- 12 Jul 2012 Actual initiation date (1 Nov 2000) added as reported by ClinicalTrials.gov.
- 27 Sep 2007 Status changed from in progress to completed.